In hepatocellular carcinoma, E2F2 has been reported to be a tumor-promoter [31], while in prostate cancer, E2F2 also has been discovered inhibition of tumor cell proliferation through regulation of miRNA let-7a [32]. The gene discussed is E2F2; the disease is prostate cancer.